PE20001092A1 - Composiciones estimulantes del crecimiento mejoradas - Google Patents

Composiciones estimulantes del crecimiento mejoradas

Info

Publication number
PE20001092A1
PE20001092A1 PE1999001104A PE00110499A PE20001092A1 PE 20001092 A1 PE20001092 A1 PE 20001092A1 PE 1999001104 A PE1999001104 A PE 1999001104A PE 00110499 A PE00110499 A PE 00110499A PE 20001092 A1 PE20001092 A1 PE 20001092A1
Authority
PE
Peru
Prior art keywords
agent
anabolic
weight
composition
controlled release
Prior art date
Application number
PE1999001104A
Other languages
English (en)
Spanish (es)
Inventor
Thomas J Kennedy
Peter J Knight
Chung Shih
Zezhi Jesse Shao
Daniel S Robins
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE20001092A1 publication Critical patent/PE20001092A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE1999001104A 1998-11-04 1999-11-03 Composiciones estimulantes del crecimiento mejoradas PE20001092A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04

Publications (1)

Publication Number Publication Date
PE20001092A1 true PE20001092A1 (es) 2000-10-31

Family

ID=22683037

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999001104A PE20001092A1 (es) 1998-11-04 1999-11-03 Composiciones estimulantes del crecimiento mejoradas

Country Status (11)

Country Link
AR (1) AR025133A1 (fr)
AU (1) AU777393B2 (fr)
BR (2) BRPI9914996B8 (fr)
CA (1) CA2348841C (fr)
CO (1) CO5140100A1 (fr)
CR (1) CR6351A (fr)
MY (1) MY134868A (fr)
PE (1) PE20001092A1 (fr)
TW (1) TWI250027B (fr)
WO (1) WO2000025743A2 (fr)
ZA (1) ZA200103494B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
EP4001288A1 (fr) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Procédé de préparation d'acétate de trenbolone présentant une distribution granulométrique définie et un habitus cristallin à plaques irrégulières hexagonales
ES2948624T3 (es) 2020-11-19 2023-09-14 Fis Fabbrica Italiana Sintetici Spa Proceso mejorado para la preparación de trembolona y/o acetato de trembolona
EP4000688A1 (fr) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Procédé pour la préparation d'acétate trenbolone ayant une distribution granulométrique définie

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573307B1 (fr) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog Implants anabolisants a liberation prolongee
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Also Published As

Publication number Publication date
BR9914996A (pt) 2001-07-10
CA2348841C (fr) 2007-04-17
AR025133A1 (es) 2002-11-13
BRPI9914996B1 (pt) 2011-11-01
MY134868A (en) 2007-12-31
AU777393B2 (en) 2004-10-14
BRPI9914996B8 (pt) 2021-07-06
AU3096700A (en) 2000-05-22
WO2000025743A3 (fr) 2000-08-24
CO5140100A1 (es) 2002-03-22
WO2000025743A2 (fr) 2000-05-11
CA2348841A1 (fr) 2000-05-11
CR6351A (es) 2003-11-20
ZA200103494B (en) 2002-07-30
BRPI9914996A (pt) 2001-07-10
TWI250027B (en) 2006-03-01

Similar Documents

Publication Publication Date Title
NO20033177L (no) Injiserbare depotpreparater og deres anvendelse
ES2174517T3 (es) Composiciones cosmeticas con dibenciliden sorbitol y siliconas funcionalizadas.
US7135194B2 (en) Subunguicide, and method for treating onychomycosis
PE20020968A1 (es) Preparados de insulina exentos de zinc y pobres en zinc, con estabilidad mejorada
PE20100265A1 (es) Nuevas composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion
CO6251259A2 (es) Formulaciones farmaceuticas de estriol en baja dosis
AR042937A2 (es) Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento
BRPI0518781A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, e, uso de um composto
PE20050775A1 (es) Formulaciones que comprenden multiparticulas de liberacion controlada
PE20070329A1 (es) Composiciones con estrogenos y metodos terapeuticos para su uso
KR890000077A (ko) 화장용 또는 국소제제로 사용하기 위한 방취 및 항균조성물
IL157841A0 (en) Activation of natural killer cells by adenosine a3 receptor agonists
EP0565668A4 (en) Biological stain composition, method of preparation and method of use for delineation of epitheleal cancer
AR065265A1 (es) Composicion y kit para prevenir o tratar una infestacion de ectoparasito en un animal de sangre caliente uso de la composicion y metodo para prevenir o tratar la infestacion
US3755575A (en) Pharmaceutical compositions
AR030037A1 (es) Sistema de administracion de anticonceptivo transdermico mejorado y el uso de una capa de soporte y una matriz polimerica para la fabricacion de un sistema de administracion de anticonceptivo
MXPA02012611A (es) Composicion anestesica, acuosa, clara.
PE20001092A1 (es) Composiciones estimulantes del crecimiento mejoradas
Gillman The effect of multiple injections of progesterone on the turgescent perineum of the baboon (Papio porcarius)
JP4823426B2 (ja) 毛髪化粧料組成物
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
PT1305057E (pt) Composicao de biomateria microparticular para uso medicinal
AR036255A1 (es) Reduccion del crecimiento del vello
BR112017000701B1 (pt) composição para tratamento de cabelo, kit e método da mesma
JPH05194140A (ja) 硫黄原子を持つアミノ酸を含有する爪処置用組成物

Legal Events

Date Code Title Description
FG Grant, registration
MK Expiration of term